Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-β1 in a cultured stellate cell line
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-10-01
著者
-
TAMURA Toru
Division of Pathology, National Institute of Health Sciences
-
Tamura Toru
キッセイ薬品工業中央研究所
-
Tamura Toru
Toxicology Research Laboratory R & D Kissei Pharmaceutical Co. Ltd.
-
Tamura Toru
信州大学 大学院総合工学系研究科
-
Inada Yoichi
Research And Development Planning Kissei Pharmaceutical Co. Ltd.
-
NAKANO Shigeru
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
NAGASAWA Tatsuya
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
IJIRO Tomoyuki
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
TAMURA Toru
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
MARUYAMA Kazuyasu
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
KURODA Junji
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
YAMAZAKI Yoshinobu
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
KUSAMA Hiroshi
Department of Development Research, Kissei Pharmaceutical Co. Ltd.
-
SHIBATA Nobuo
Research and Development Division, Kissei Pharmaceutical Co. Ltd.
-
Kagami Hiroshi
Fac. Of Agriculture Shinshu Univ. Jpn
-
Kusama Hiroshi
Toxicology Research Laboratory R&d Kissei Pharmaceutical Co. Ltd.
-
Ijiro Tomoyuki
Department Of Development Research Kissei Pharmaceutical Co. Ltd.
-
Kusama Hiroshi
Department Of Development Research Kissei Pharmaceutical Co. Ltd.
-
Kuroda Junji
Toxicology Lab. Kissei Pharmaceutical Co. Ltd.
-
Kuroda J
Toxicology Research Laboratory R&d Kissei Pharmaceutical Co. Ltd.
-
Kuroda Junji
Toxicology
-
Nagasawa Tatsuya
Toxicology Research Laboratory R & D Kissei Pharmaceutical Co. Ltd.
-
Maruyama Kazuyasu
Department Of Development Research Kissei Pharmaceutical Co. Ltd.
-
Yamazaki Yoshinobu
Department Of Development Research Kissei Pharmaceutical Co. Ltd.
-
Kusama Hiroshi
キッセイ薬品工業安全性研究所
-
Shibata Nobuo
Research And Development Division Kissei Pharmaceutical Co. Ltd.
-
Shibata Nobuo
Toxicology Research Laboratory R&d Kissei Pharmaceutical Co. Ltd.
-
Tamura Toru
Department Of Civil Engineering The University Of Tokyo
-
Kasahara Hiroko
Toxicology Research Laboratory R & D Kissei Pharmaceutical Co. Ltd.
-
Nakano Shigeru
Department Of Development Research Kissei Pharmaceutical Co. Ltd.
-
Tamura Toru
Div. Of Pathology Nihs
関連論文
- Comparison of enhancing effects of different goitrogen treatments in combination with β-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds
- Lack of Modifying Effects of Combined Treatment of t-butylhydroquinone and Sodium Nitrite on Forestomach Carcinogenesis in rasH2 Mice Initiated with N-ethyl-N-nitrosourea
- Tumorigenic Susceptibility of Catechol on the Gastric Mucosa in rasH2 Mice
- Lack of Modifying Effect of Glycerol in Pulmonary Carcinogenesis in rasH2 Mice Induced by Urethane or 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
- LACK OF MODIFYING EFFECTS OF EUGENOL ON DEVELOPMENT OF LUNG PROLIFERATIVE LESIONS INDUCED BY URETHANE IN TRANS-GENIC MICE CARRYING THE HUMAN PROTOTYPE c-Ha-ras GENE
- Lack of Modifying Effects of Cinnamaldehyde on Development of Lung Proliferative Lesions Induced by Urethane in Transgenic Mice Carrying the Human Prototype c-Ha-ras Gene
- Modulatory effects of hepatic, renal or thyroidal impairments on amitrole-induced thyroid carcinogenesis in rats pretreated with DHPN (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Safety evaluetion of Bt protein by dietary administration to a gastro-intestinal impairment rat model (GENERAL TOXICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Modifying Effects of 2,6-Dimethylaniline on Nasal Carcinogenesis in RasH2 Mice Initiated with 4-Methylnitrosamino)-1-(3-pyridyl)-1-butanone
- Lack of Modifying Effects of 2,6-Dimethylaniline on Lung Carcinogenesis in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene Initiated with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone